Login to Your Account



Other News To Note


Wednesday, October 16, 2013

• Kymab Ltd., of Cambridge, UK, said it notified the English Court that it will defend the UK patent proceedings brought by Tarrytown, N.Y.-based Regeneron Pharmaceuticals Inc. in respect of European patent EP1360287. Regeneron initiated the proceedings in September. Kymab said it will defend the UK patent action on the grounds of non-infringement and invalidity of the patent.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription